Effect of recombinant factor VIIa as an adjunctive therapy in damage control for wartime vascular injuries: A case control study

Journal of Trauma - Injury, Infection and Critical Care

Volumn 66, Issue SUPPL. 4, 2009, Pages

  Fox, Charles J ^a,b   Mehta, Sumeru G ^c   Cox, E Darrin ^d   Kragh Jr , John F ^e   Salinas, Jose ^e   Holcomb, John B ^e  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

^d WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^e US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

Coagulopathy; Combat; Damage control; Factor VIIa; Military; Resuscitation; Vascular trauma; Wartime

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A; COAGULATING AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ACIDOSIS; ADOLESCENT; ADULT; AGED; AMPUTATION; ANEMIA; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD VESSEL GRAFT; BLOOD VESSEL INJURY; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT INFECTION; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPERATION DURATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESUSCITATION; SCHOOL CHILD; THROMBOSIS; VASCULAR SURGERY; WAR; BLOOD; BLOOD VESSEL; CASE CONTROL STUDY; EMERGENCY HEALTH SERVICE; INJURY; LIMB SALVAGE; PENETRATING TRAUMA; PRACTICE GUIDELINE; REGISTER; RETROSPECTIVE STUDY; SOLDIER;

ACIDOSIS; ADOLESCENT; ADULT; BLOOD VESSELS; CASE-CONTROL STUDIES; COAGULANTS; FACTOR VIIA; FEMALE; HEMORRHAGE; HUMANS; IRAQ WAR, 2003 -; LIMB SALVAGE; MALE; MILITARY PERSONNEL; PRACTICE GUIDELINES AS TOPIC; RECOMBINANT PROTEINS; REGISTRIES; RETROSPECTIVE STUDIES; TRAUMA CENTERS; VASCULAR SURGICAL PROCEDURES; WOUNDS, PENETRATING; YOUNG ADULT;

EID: 68049089941     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31819ce240     Document Type: Article

References (30)

1. Holcomb JB, McMullin NR, Pearse L, et al. Causes of death in US Special Operations Forces in the Global War on Terrorism 2001-2004. Ann Surg. 2007;245:986 -991.
2. Fox CJ, Starnes BW. Vascular surgery on the modern battlefield. Surg Clin North Am. 2007;87:1193-211, xi.
3. Kragh JF Jr, Walters TJ, Baer DG, et al. Practical use of emergency tourniquets to stop bleeding in major limb trauma. J Trauma. 2008; 64:S38 -S49.
4. Rasmussen TE, Clouse WD, Jenkins DH, et al. Echelons of care and the management of wartime vascular injury: a report from the 332nd EMDG/Air Force Theater Hospital, Balad Air Base, Iraq. Perspect Vasc Surg Endovasc Ther. 2006;18:91-99.
5. Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma. 2003;54:1127-1130.
6. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55:39-44.
7. Fox CJ, Gillespie DL, Cox ED, et al. Damage control resuscitation for vascular surgery in a combat support hospital. J Trauma. 2008;65:1-9.
8. Cosgriff N, Moore EE, Sauaia A, et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma. 1997;42:857- 861.
9. CENTCOM CPG. Recombinant Factor VIIa [database on the Internet]: US Department of Defense. Available at: https://jpta.fhp.osd.mil. Accessed 2007.
10. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005;59:8 -15.
11. Perkins JG, Schreiber MA, Wade CE, et al. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion. J Trauma. 2007;62:1095-1101.
12. Beekley AC. Damage control resuscitation: a sensible approach to the exsanguinating surgical patient. Crit Care Med. 2008;36:S267-S274.
13. Alam HB, Rhee P. New developments in fluid resuscitation. Surg Clin North Am. 2007;87:55-72, vi.
14. Borgman MA, Spinella PC, Perkins J, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805-813.
15. Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion. 2006;46:685- 686.
16. Gonzalez EA, Moore FA, Holcomb JB, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion 1. J Trauma. 2007;62:112-119.
17. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma 1. J Trauma. 2007;62:307-310.
18. Tieu BH, Holcomb JB, Schreiber MA. Coagulopathy: its pathophysiology and treatment in the injured patient. World J Surg. 2007;31:1055-1065.
19. Holcomb JB. Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma. J Trauma. 2005;58:1298 -1303.
20. Holcomb JB, Hoots K, Moore FA. Treatment of an acquired coagulopathy with recombinant activated factor VII in a damagecontrol patient. Mil Med. 2005;170:287-290.
21. Holcomb JB. Methods for improved hemorrhage control. Crit Care. 2004;8 (Suppl 2):S57-S60.
22. Klemcke HG, Delgado A, Holcomb JB, et al. Effect of recombinant FVIIa in hypothermic, coagulopathic pigs with liver injuries. J Trauma. 2005;59:155-161.
23. McMullin NR, Kauvar DS, Currier HM, et al. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy. Curr Surg. 2006;63:246-251.
24. Mohr AM, Holcomb JB, Dutton RP, Duranteau J. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma. Crit Care. 2005;9 (Suppl 5):S37-S42.
25. Schreiber MA, Holcomb JB, Rojkjaer R. Preclinical trauma studies of recombinant factor VIIa. Crit Care. 2005;9 (Suppl 5):S25-S28.
26. White CE, Schrank AE, Baskin TW, et al. Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage. Curr Surg. 2006;63:310 -317.
27. Rizoli SB, Boffard KD, Riou B, et al. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit Care. 2006;10:R178.
28. Spinella PC, Perkins JG, McLaughlin DF, et al. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma. 2008;64:286 -293.
29. Mazer CD, Leong-Poi H, Mahoney J, et al. Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa. Semin Cardiothorac Vasc Anesth. 2007;11:261-264.
30. Fox CJ, Gillespie DL, Cox ED, et al. The effectiveness of a damage control resuscitation strategy for vascular injury in a combat support hospital: results of a case control study. J Trauma. 2008;64:S99 -106.